Reveleer, an AI-enabled value-based care technology company serving health plans and provider organizations, today announced the appointment of Fadi Almachraki as Chief Technology Officer. Almachraki will lead Reveleer’s software engineering, data science, AI, development operations, corporate IT, and information security organizations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112277663/en/

Almachraki joins Reveleer after 15 years building AI for healthcare in settings where clinical decisions carry financial weight. At Post Acute Analytics he served as Chief Product & Technology Officer and, before that, as Chief Data Science Officer; he built and deployed a patent-pending generative AI application supporting prior authorization decisions, led a large product and technology organization, and installed secure-by-design engineering practices aligned with HITRUST r2 certification and SOC 2 Type II audit. Earlier he served as Chief Data Science Officer at KelaHealth, where his team deployed machine learning models predicting surgical complications for hospital clients, and as Head of Data Science & AI at Sempre Health. He spent eight years at DaVita as Director of Healthcare AI, building clinical decision support algorithms, and leading the healthcare economics team.

Reveleer has processed more than 2 billion pages of medical records for risk adjustment and quality programs, and its EVE™ AI links each suggestion to the page where the supporting evidence appears so coders and clinicians can verify it before making a final decision. Almachraki will own the platform architecture behind that work, including the data, AI, and security foundations that more than 80 customer organizations rely on.

“Fadi has spent his career building AI for clinicians and health plans in environments where the data is messy and the stakes are real,” said Jay Ackerman, CEO of Reveleer. “He builds teams who hold a high bar and ship, and that’s what it takes to scale explainable AI across every product on the Reveleer Platform.”

“Value-based care only works when the people paying for and delivering care can see the whole patient: accurate risk, closed care gaps, and clinical evidence they can trust,” said Almachraki. “Reveleer sits at the center of that work, helping health plans and providers turn clinical data into better outcomes and more sustainable economics. Technology decides how far and how fast that work goes. My job is to build a technology community where great engineers, data scientists, and AI practitioners do the best work of their careers; a place that holds a high bar, learns quickly, and delivers AI that is explainable, secure, and useful to our customers.”

Almachraki holds a Master of Science in Computer Science from the Georgia Institute of Technology and a Bachelor of Science in Chemical Engineering from the University of California, Berkeley, and is completing an Executive MBA at the Wharton School of the University of Pennsylvania. He holds a U.S. patent for automating prescription refills through machine navigation of pharmacy interactive voice response systems, and he began his career as an engineer at NASA’s Jet Propulsion Laboratory.

About Reveleer

Reveleer delivers a unified platform spanning risk adjustment, quality improvement, clinical intelligence, and member management for health plans and provider organizations navigating the complexity of value-based care. Trusted by more than 80 customer organizations nationwide, the platform integrates data, analytics, and intelligent workflow automation into one governed system designed to support traceable documentation across diagnoses, quality measures, and submissions. With regulatory expertise and transparent, human-in-the-loop AI at its core, Reveleer supports organizations working to advance care quality, strengthen documentation integrity, and sustain the operational readiness needed to navigate audits with confidence. Learn more at reveleer.com.

Media gallery

About The Author
Business Wire